Gastro Medical News about cholera

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial : The Lancet
The Lancet - Early Online Publication, 10/09/09

Sur D et al. – This modified killed–whole–cell oral vaccine, compliant with WHO standards, is safe, provides protection against clinically significant cholera in an endemic setting, and can be used in children aged 1·0—4·9 years, who are at highest risk of developing cholera in endemic settings.

<< Previous
Pre-S2 deletions of hepatitis B virus and hepatocellular...

Next >>
Initial experience with laparoscopic Chait Trapdoor cecostomy...

Epidemics of severe cholera caused by El Tor Vibrio cholerae O1 Ogawa possessing the ctxB gene of the classical biotype in Orissa, India
International Journal of Infectious Diseases, 10/01/09 Relevance Score: 91%

Clinical Outcomes in Household Contacts of Patients with Cholera in Bangladesh
Clinical Infectious Diseases, 10/28/09 Relevance Score: 90%

A multiplatform real-time polymerase chain reaction detection assay for Vibrio cholerae
Diagnostic Microbiology and Infectious Disease, 10/22/09 Relevance Score: 90%

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial
The Lancet, 11/16/09 Relevance Score: 89%

Quorum sensing negatively regulates hemolysin transcriptionally and post-translationally in Vibrio cholerae
Infection and Immunity, 10/30/09 Relevance Score: 87%